FGN Futuragene

 

TIDMFGN 
 
 
Futuragene PLC 
15 April 2009 
 
? 
 
 
 
 
FUTURAGENE PLC ("FuturaGene" or the "Company") 
 
 
FuturaGene's Wholly Owned Subsidiary, CBD Technologies, Ltd. (FGN's CBD Tech) 
announces the granting of plant cell wall modification patent in Japan. 
 
 
Rehovoth, Israel 
15 April, 2009 
 
 
FuturaGene, which develops environmentally friendly solutions that enhance crop 
yields and improve the processability of plants for forestry, biofuels, biopower 
and agriculture is pleased to announce that its wholly owned subsidiary, CBD 
Technologies Ltd. ("CBD Tech"), has been granted Japanese patent no. 4276780 
entitled " Transgenic plants of altered morphology and the isolated arabidposis 
thaliana endo-1,4-beta-glucanase gene, promoter and protein". The patent claims, 
inter alia, transgenic plants of altered morphology, expressing cellulose 
binding domains or endo-1,4-beta-glucanase enzymes, which are cell wall 
modifying proteins. The altered morphology includes higher biomass, faster 
growth rate, higher yield, higher cellulose content, more amenable for digestion 
by ruminants or increased resistance to heat, biodegradation or pests. 
 
 
Dr. Stanley Hirsch, Group CEO of FuturaGene said "This patent consolidates our 
global intellectual property position in the critical area of cell wall 
modification, which is a fundamental technology for yield enhancement in plants. 
This is highly significant for the sustainable industrial forestry, biofuel and 
biopower sectors. Japan is home to some of the world's largest pulp and paper 
producers, enhancing the significance of this patent." 
 
 
 
 
FuturaGene Plc 
Mark Pritchard, Chairman 
                     +44 (0) 7802 827 846 
Dr. Stanley Hirsch, Group CEO 
                       +972 544 56 2724 
 
 
Evolution Securities 
Neil Elliot 
                                 +44 (0) 20 7071 4300 
 
 
 
 
About FuturaGene PLC 
FGN is a leading agricultural biotechnology company focused on research, 
development, and commercialisation of technologies that play key roles in 
substantially improving agronomic traits of value in plants. In particular the 
Company is focused on the development and commercialisation of genetically 
modified plants for improving and protecting yields, and enhancing 
processability and environmental sustainability in the forestry, biofuels, 
biopower and agricultural sectors. FuturaGene licenses intellectual property 
from leading universities in its strategic fields of interest and is exploiting 
the synergies of these technologies with the cell wall modification platform of 
its wholly owned subsidiary, CBD Technologies, Inc. (CBD Tech) in forestry, 
biofuel,  food and feed crops. 
CBD Tech has pioneered a modality for altered cell walls, resulting in enhanced 
growth and biomass, increased cellulose, improved fiber properties, improved 
digestibility and processability, and increased yield properties and has secured 
broad intellectual property covering plants with modified cell walls showing 
such altered properties. More information is available at www.futuragene.com. 
 
 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 NRASFWFFISUSEIL 
 

Futuragene (LSE:FGN)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024

Futuragene (LSE:FGN)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024